Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
new york blog main
new york top stories
3
×
third rock ventures
3
×
biogen
biotech
boston blog main
boston top stories
clinical trials
gene therapy
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
startups
acadia pharmaceuticals
acetylon pharmaceuticals
adverum biotechnologies
aimmune
alk
ambys medicines
amgen
antisense oligonucleotide
avalon ventures
aveo oncology
benzodiazepines
blackstone group
blackstone life sciences
boston
bristol-myers squibb
cell therapy
cerevel therapeutics
clinical data
columbia university
constellation pharmaceuticals
david goldstein
deals
depression
What
medicines
new
advanced
aiming
aims
ambys
arrival
award
backed
big
bio
biotech
cancer
cause
ceo
control
data
deadly
deal
death
debuted
decades
dems
diseases
drug
drugs
epilepsy
formed
future
genes
genetic
given
immunotherapy
launch
links
liver
longer
lung
make
marcio
Language
unset
Current search:
" third rock ventures "
×
" new york top stories "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
